13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001104659-26-014463
Total Value
$865.2M
Positions
8
Other Managers
0
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 4,659,874 | $362.6M | 41.91% |
| 2 | Dyne Therapeutics, Inc. | DYN | 9,130,465 | $178.6M | 20.64% |
| 3 | Sionna Therapeutics, Inc. | SION | 2,995,602 | $123.2M | 14.24% |
| 4 | Disc Medicine, Inc. | IRON | 1,513,875 | $120.2M | 13.90% |
| 5 | Day One Biopharmaceuticals, Inc. | DAWN | 6,412,560 | $59.8M | 6.91% |
| 6 | Korro Bio, Inc. | KRRO | 1,137,149 | $9.1M | 1.05% |
| 7 | Q32 Bio, Inc. | QTTB | 2,092,106 | $6.9M | 0.80% |
| 8 | Generation Bio, Co. | 37148K209 | 827,946 | $4.7M | 0.54% |